See the latest news and media coverage for IDMED. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device developer and marketer for anesthesia and intensive care
idmed.frLast updated
In short: IDMED launched next-generation TOFscan and validated the NeuroLight QPi pupillometry score for patients with acute brain injuries.
New peer-reviewed data confirms strong correlation with reference measurements and high sensitivity in ICU cohorts. This study reinforces the clinical value of standardized quantitative pupillometry for neurocritical care. #MedTech #NeuroLight
The post references Gland Pharma's FDA approval for generic sugammadex and stresses that objective TOF monitoring remains essential despite the drug.
Quantitative Pupillary index is evaluated and validated as a prognostic tool in a multicentre prospective study on cardiac arrest patients.
These are the first to explicitly recommend quantitative neuromuscular monitoring before tracheal intubation. This milestone underscores its essential role across the entire anaesthetic pathway.
Located in Marseille, this company develops different technologies for operating rooms, its flagship product allowing to measure the pain of a sleeping patient thanks to the...
IDMed, located at the Technopôle de Château Gombert in Marseille and housed within the Technoptic hotel of Marseille Innovation, develops and markets systems...
After fifteen years spent filming the eye for an optics company, Thierry Bagnol and Frédéric Bernert have acquired the certainty that one can...
Medical The Marseille-based company, which has developed a portable pupillometer intended to help anesthesiologists perfect their dosage, enters the commercialization phase. ...
Track IDMED and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to IDMED and other trending companies.